Fondazione Telethon Announces Historic FDA Approval of Waskyra
December 11, 2025
December 11, 2025
BOSTON, Massachusetts, Dec. 11 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Fondazione Telethon Announces Historic FDA Approval of Waskyra
*
Goodwin congratulates Fondazione Telethon on receiving approval from the U.S. Food and Drug Administration (FDA) of its Biologics License Application for Waskyra(tm), an ex vivo gene therapy for patients with Wiskott-Aldrich syndrome, a rare and life-threatening . . .
* * *
Fondazione Telethon Announces Historic FDA Approval of Waskyra
*
Goodwin congratulates Fondazione Telethon on receiving approval from the U.S. Food and Drug Administration (FDA) of its Biologics License Application for Waskyra(tm), an ex vivo gene therapy for patients with Wiskott-Aldrich syndrome, a rare and life-threatening . . .
